[
    [
        {
            "time": "",
            "original_text": "高瓴资本概念股涨势强劲，泰格医药、凯莱英、金域医学、恩捷股份等集体上扬",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "涨势强劲",
                    "泰格医药",
                    "凯莱英",
                    "金域医学",
                    "恩捷股份"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股涨势强劲，泰格医药、凯莱英、金域医学、恩捷股份等集体上扬",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业报告：中外新冠疫苗PK 孰优孰劣？",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业报告",
                    "新冠疫苗",
                    "中外对比"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业报告：中外新冠疫苗PK 孰优孰劣？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "刚刚，周期股大爆发！A股冲上3600点，央妈又放大招！港股冲击3万点，返乡新规引爆700亿巨头！这只股彻底崩了，连砸五跌停！",
            "features": {
                "keywords": [
                    "周期股",
                    "A股",
                    "3600点",
                    "央妈",
                    "港股",
                    "3万点",
                    "返乡新规",
                    "700亿巨头",
                    "五跌停"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "周期股",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "刚刚，周期股大爆发！A股冲上3600点，央妈又放大招！港股冲击3万点，返乡新规引爆700亿巨头！这只股彻底崩了，连砸五跌停！",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "受益于良好的业绩预期，这3只医药股涨幅均超60%",
            "features": {
                "keywords": [
                    "业绩预期",
                    "医药股",
                    "涨幅超60%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "受益于良好的业绩预期，这3只医药股涨幅均超60%",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "52只股北向资金持有流通盘的比例超10%",
            "features": {
                "keywords": [
                    "北向资金",
                    "流通盘",
                    "比例超10%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "52只股北向资金持有流通盘的比例超10%",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]